What Are the Side Effects of Wegovy for Weight Loss?

Which side effects do most people on Wegovy actually notice?

The side effects of Wegovy for weight loss are well-documented across large clinical trials, and the pattern is clear: the gut leads the way. Nausea is the most frequently reported experience, followed by vomiting, diarrhoea, constipation, burping, and acid reflux. Fatigue, headache, and dizziness also appear in the data, though less often. If you're reading this because you've just started or you're about to, that mix of anticipation and apprehension is entirely understandable, most people have exactly that feeling before their first dose.

The timing matters. Effects are typically most pronounced in the 24–72 hours after an injection, and they tend to be sharper after each dose increase than they were at the previous level. The semaglutide side-effect pattern generally follows the titration curve: the 0.25mg starting dose is chosen partly to let your system settle before moving up. By the time patients reach maintenance, many find the GI effects have become much more manageable or have resolved altogether. NHS guidance on semaglutide confirms this picture and recommends eating smaller, lower-fat meals and staying well-hydrated as practical ways to reduce nausea during the early weeks.

Injection-site reactions (redness, mild swelling, or itching where the pen was used) are also possible. Rotating between the abdomen, thigh, and upper arm each week reduces the likelihood. None of this is inevitable; a meaningful proportion of people experience only mild or very brief effects. But going in with accurate expectations is useful.

When should a Wegovy side effect prompt urgent medical help?

Most side effects of Wegovy for weight loss are self-limiting, but a small number of effects require you to stop and seek help promptly rather than wait. Knowing the difference matters.

Acute pancreatitis is an uncommon but potentially serious risk across GLP-1 medicines. In January 2026, the MHRA published a Drug Safety Update specifically highlighting this; the signal to watch for is severe, persistent abdominal pain that may reach through to your back, with or without vomiting. If that describes what you're feeling, seek emergency care rather than managing it at home. Our detailed guide to taking Wegovy and its effects covers this in more depth.

Other symptoms that warrant urgent attention include: signs of a serious allergic reaction (swelling of the face, lips or throat, difficulty breathing, rapid heart rate); symptoms suggesting gallbladder problems (pain in the upper right abdomen, particularly after eating); or significant dehydration resulting from persistent vomiting or diarrhoea, particularly if you are unable to keep fluids down for more than a day. Kidney function can be affected when someone becomes severely dehydrated on a GLP-1 medicine, so this is not a symptom to push through.

Semaglutide is not recommended during pregnancy, while breastfeeding, or for anyone trying to conceive, and it is not licensed for under-18s. If any of these circumstances change during treatment, talk to your prescriber promptly. Full contraindication detail is in the Patient Information Leaflet supplied with your pen.

Are there side effects that build up over a longer period?

Patients and prescribers reasonably ask whether sustained use brings different concerns from short-term use. The STEP clinical trial programme, which underpins Wegovy's UK licence, followed participants for up to 68 weeks, and the longer-term side-effect picture is more reassuring than many people expect. Serious adverse events were uncommon in trial populations, and the most-reported effects remained gastrointestinal rather than systemic.

There is ongoing pharmacovigilance for all Black Triangle medicines, which Wegovy remains, meaning the MHRA actively collects post-marketing data. That does not imply unknown danger; it reflects the standard monitoring applied to newer medicines approved within roughly the last five years. NICE's appraisal of semaglutide (TA875) included a maximum recommended treatment duration of two years within NHS specialist services, though the clinical rationale for that limit within a private setting is a prescriber discussion rather than a blanket rule.

The question of whether Wegovy is safe for weight loss in the longer run is one our prescribers address in every review, because individual circumstances change. If a concern arises between reviews, the aftercare line is there. Suspected side effects (your own or someone else's) can be reported to the MHRA at yellowcard.mhra.gov.uk; this reporting is genuinely useful in building the evidence base for medicines still under active surveillance.

How does a clinical review help you manage Wegovy side effects?

Side-effect management is one of the most practical reasons to have ongoing prescriber oversight rather than simply receiving a medicine and being left to it. Dose increases are where effects tend to spike, and a prescriber who reviews your progress before each step can decide whether you're ready to move up or whether staying at the current level for another few weeks is the right call for you specifically.

At nume, a named prescriber (not an automated system) reads your consultation and every subsequent check-in. Our Wegovy side effects page covers the management strategies prescribers most commonly suggest, from meal timing to hydration approaches. If you're weighing up treatment options or want to understand how Wegovy compares to tirzepatide before starting, the weight-loss treatment overview sets out the licensed options plainly. Pricing context, including what a private prescription covers beyond the medicine itself, is explained on the Wegovy prices page.

The conversation about side effects begins at the free consultation, not after your first pen arrives. Speak to our prescribers about your medical history, any medicines you currently take, and how the titration schedule is likely to feel for you, that conversation shapes the plan before anything is dispensed.